YOLFTbeta
Reckitt Benckiser Group PLC

Reckitt Benckiser Group PLC

RKT · LSE · Consumer Defensive / Household & Personal Products

5,702.00GBX+34.00 (+0.60%)

Price History

Full chart

Market Stats

Previous Close5,668.00
Open5,668.00
Day Range5,650.00 – 5,718.00
52-Week Range3,603.23 – 6,252.77
Volume798.09K
Market Cap31.22B
P/E (TTM)11.09
Forward P/E14.14
EPS4.44
Dividend Yield4.39%
Beta0.25
50-Day Avg5,101.88
200-Day Avg5,300.74

About

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Kristoffer Loe Licht
  • Employees36.20K
  • HeadquartersTurner House, Slough, United Kingdom, SL1 3UH, UK
  • Websitehttps://www.reckitt.com

Leadership

  • Mr. Kristoffer Loe LichtCEO & Executive Director · b. 1976
  • Ms. Shannon Sue EisenhardtCFO & Executive Director · b. 1974
  • Mr. Nicholas James Ashworth C.F.A.Senior Vice President of Investor Relations
  • Ms. Catheryn O'RourkeSenior VP, General Counsel & Company Secretary · b. 1973
  • Ms. Sheila RedzepiChief Communications & Corporate Affairs Officer · b. 1979
  • Mr. Ranjay RadhakrishnanChief Human Resources Officer · b. 1971
  • Mr. Jerome LemairePresident North America · b. 1974
  • Ms. Angela Naef Ph.D.Chief Research & Development Officer · b. 1976
  • Ms. Susan SholtisPresident of Nutrition · b. 1967
  • Dr. Alessio Fasano M.D.Chief Science & Medical Officer of Mead Johnson Nutrition (MJN) Business

Financials

Income Statement

Currency: GBP2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.45B3.71B3.87B4.18B4.92B5.27B6.56B7.75B8.45B9.48B9.57B10.04B8.84B8.87B9.48B11.45B12.60B12.85B13.99B13.23B14.45B14.61B14.17B14.21B
Growth (%)-+7.50%+4.26%+7.96%+17.78%+7.05%+24.56%+18.13%+9.03%+12.21%+0.86%+4.98%-12.02%+0.43%+6.83%+20.77%+10.03%+1.98%+8.93%-5.42%+9.21%+1.07%-3.00%+0.25%
Cost of Revenue1.68B1.74B1.75B1.89B2.13B2.20B2.67B3.09B3.33B4.04B4.03B4.07B3.74B3.63B3.68B4.47B4.96B5.15B5.56B5.54B6.09B5.85B5.57B5.71B
Gross Profit1.78B1.98B2.12B2.29B2.79B3.07B3.89B4.66B5.12B5.46B5.54B5.97B5.10B5.25B5.80B6.98B7.63B7.78B8.44B7.69B8.36B8.76B8.60B8.49B
Gross Margin51.42%53.27%54.79%54.87%56.66%58.30%59.27%60.16%60.58%57.52%57.88%59.43%57.67%59.12%61.19%60.98%60.61%60.55%60.28%58.11%57.85%59.97%60.66%59.77%
Operating Expense1.20B1.30B1.37B1.45B1.88B1.84B2.38B2.77B2.99B3.06B3.10B4.08B2.92B3.00B3.53B4.25B4.59B4.49B6.28B8.49B5.11B6.23B6.17B5.08B
Operating Income576.00M679.00M749.00M840.00M910.00M1.23B1.50B1.89B2.13B2.40B2.44B1.89B2.18B2.24B2.27B2.74B3.05B3.29B2.16B-804.00M3.25B2.53B2.42B3.42B
Operating Margin16.68%18.29%19.35%20.10%18.49%23.40%22.93%24.39%25.20%25.25%25.45%18.79%24.64%25.25%23.93%23.91%24.19%25.59%15.44%-6.08%22.48%17.33%17.11%24.05%
EBITDA679.00M792.00M879.00M981.00M1.02B1.35B1.64B2.03B2.29B2.57B2.59B2.05B2.34B2.42B2.48B2.98B3.50B-1.32B3.48B465.00M3.90B3.19B2.95B3.92B
EBITDA Margin19.66%21.33%22.71%23.47%20.82%25.58%25.05%26.24%27.11%27.05%27.09%20.41%26.46%27.30%26.19%26.04%27.79%-10.29%24.91%3.51%27.01%21.83%20.82%27.56%
Net Income408.00M489.00M577.00M669.00M674.00M938.00M1.12B1.42B1.57B1.75B1.83B1.74B1.66B1.74B1.83B3.38B2.16B-2.77B1.19B-32.00M2.33B1.64B1.43B3.18B
Net Income Margin11.81%13.17%14.91%16.01%13.69%17.80%17.07%18.29%18.55%18.40%19.12%17.32%18.82%19.64%19.32%29.49%17.15%-21.58%8.48%-0.24%16.12%11.25%10.06%22.40%
R&D54.00M57.00M59.00M60.00M78.00M88.00M105.00M122.00M33.00M26.00M171.00M152.00M146.00M140.00M149.00M187.00M230.00M257.00M288.00M313.00M325.00M337.00M325.00M316.00M
R&D as % of Total Revenue1.56%1.54%1.52%1.44%1.58%1.67%1.60%1.57%0.39%0.27%1.79%1.51%1.65%1.58%1.57%1.63%1.83%2.00%2.06%2.37%2.25%2.31%2.29%2.22%
Interest Expense52.00M43.00M27.00M14.00M54.00M46.00M62.00M16.00M12.00M38.00M49.00M56.00M65.00M46.00M52.00M254.00M403.00M314.00M328.00M264.00M267.00M318.00M385.00M430.00M
Interest Expense % of Total Revenue1.51%1.16%0.70%0.34%1.10%0.87%0.94%0.21%0.14%0.40%0.51%0.56%0.74%0.52%0.55%2.22%3.20%2.44%2.34%1.99%1.85%2.18%2.72%3.03%

Balance Sheet

Currency: GBP2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.32B3.47B3.51B3.82B3.85B4.21B5.74B5.87B9.18B8.66B13.42B14.13B15.08B15.15B15.50B15.27B18.02B37.01B37.65B32.14B31.29B26.95B28.74B27.14B25.30B25.07B
Total Liabilities2.19B2.18B2.30B2.35B2.27B2.36B3.87B3.48B5.89B4.65B8.29B8.35B9.16B8.81B8.66B8.36B9.59B23.44B22.86B22.73B22.13B19.49B19.26B18.67B18.58B17.29B
Total Equity1.12B1.28B1.20B1.47B1.58B1.85B1.86B2.38B3.29B4.01B5.06B5.71B5.92B6.33B6.83B6.90B8.42B13.53B14.74B9.36B9.12B7.40B9.44B8.45B6.70B7.75B
Cash94.00M89.00M40.00M59.00M308.00M978.00M305.00M328.00M417.00M351.00M588.00M639.00M887.00M808.00M917.00M740.00M882.00M2.13B1.48B1.55B1.65B1.26B1.16B1.39B760.00M1.95B
Total Debt--524.00M491.00M246.00M163.00M979.00M492.00M1.57B136.00M2.64B2.51B3.27B2.77B2.57B2.42B2.39B12.86B12.16B12.20B10.56B9.56B8.88B8.54B8.66B8.43B
Net Debt--484.00M432.00M-62.00M-815.00M674.00M164.00M1.16B-215.00M2.06B1.87B2.39B1.96B1.66B1.68B1.51B10.74B10.40B10.65B8.91B8.30B7.73B7.15B7.90B6.48B

Cash Flow

Currency: GBP2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow439.00M526.00M695.00M773.00M1.02B953.00M1.30B1.93B1.52B1.72B1.89B2.12B2.10B1.78B2.42B2.49B2.45B1.41B3.52B1.70B2.40B2.64B2.68B2.30B
Investing Cash Flow-405.00M-500.00M1.00M478.00M-1.91B150.00M-1.22B-109.00M-2.77B-626.00M-936.00M-630.00M-715.00M-134.00M-583.00M-8.90B-422.00M-442.00M-512.00M239.00M-139.00M-466.00M-396.00M1.20B
Financing Cash Flow-59.00M-10.00M-556.00M-592.00M233.00M-1.11B-38.00M-1.88B1.47B-1.00B-688.00M-1.52B-1.19B-1.80B-1.77B7.74B-2.62B-830.00M-2.86B-2.29B-2.38B-1.81B-2.71B-2.43B
Capital Expenditure99.00M156.00M83.00M78.00M88.00M134.00M216.00M158.00M367.00M205.00M177.00M225.00M157.00M154.00M176.00M286.00M437.00M443.00M486.00M450.00M443.00M449.00M465.00M536.00M
Free Cash Flow340.00M370.00M612.00M695.00M929.00M819.00M1.09B1.77B1.16B1.51B1.71B1.90B1.94B1.63B2.25B2.21B2.02B968.00M3.03B1.25B1.95B2.19B2.22B1.76B
Dividends Paid--216.00M262.00M300.00M358.00M441.00M648.00M773.00M873.00M916.00M992.00M988.00M924.00M1.03B1.13B1.19B1.23B1.24B1.25B1.25B1.34B1.38B1.40B
FCF to OCF77.45%70.34%88.06%89.91%91.35%85.94%83.41%91.81%75.93%88.07%90.63%89.39%92.52%91.37%92.73%88.52%82.19%68.60%86.19%73.48%81.52%82.97%82.66%76.67%
Dividend Paid to FCF--35.29%37.70%32.29%43.71%40.61%36.59%66.75%57.70%53.54%52.32%50.88%56.69%46.08%51.43%58.85%126.76%40.93%99.92%63.92%61.23%62.29%79.67%

Earnings

Report DateApr 27, 2006Jul 24, 2006Oct 24, 2006Feb 8, 2007Apr 26, 2007Jul 25, 2007Oct 24, 2007Feb 13, 2008Apr 24, 2008Jul 28, 2008Oct 27, 2008Feb 11, 2009Apr 28, 2009Jul 29, 2009Oct 27, 2009Feb 10, 2010Apr 27, 2010Jul 27, 2010Nov 2, 2010Feb 9, 2011Apr 20, 2011Jul 25, 2011Oct 25, 2011Feb 8, 2012Oct 21, 2013Feb 12, 2014Jul 28, 2014Feb 11, 2015Jul 27, 2015Feb 15, 2016Jul 29, 2016Oct 19, 2016Feb 10, 2017Apr 21, 2017Jul 24, 2017Oct 18, 2017Feb 19, 2018Apr 20, 2018Jul 27, 2018Oct 30, 2018Feb 18, 2019May 2, 2019Jul 30, 2019Oct 22, 2019Feb 27, 2020Apr 30, 2020Jul 28, 2020Oct 20, 2020Feb 24, 2021Apr 28, 2021Jul 27, 2021Oct 26, 2021Feb 17, 2022Apr 29, 2022Jul 27, 2022Oct 26, 2022Mar 1, 2023Apr 26, 2023Jul 26, 2023Oct 26, 2023Feb 28, 2024Apr 24, 2024Jul 24, 2024Oct 23, 2024Mar 6, 2025Jul 24, 2025Dec 31, 2025
EPS Estimate------------------------71.911.47112.32143.0398.30145.35112.430.00178.560.00129.380.00198.050.00143.710.00196.780.00146.880.00201.400.00159.470.00162.300.00148.460.00157.270.00145.000.00167.230.00174.060.00166.650.000.000.001.541.625.37
EPS Actual15.5621.4322.3236.5425.3030.5836.1641.2229.3534.0041.1256.8743.8644.7951.6762.8149.4953.8560.7758.8150.2957.2065.8173.750.001.790.000.000.000.000.000.001.750.001.090.001.660.001.220.001.830.001.380.00-5.310.001.440.000.150.00-2.460.002.370.001.880.001.380.000.000.000.000.001.610.001.881.41-
Surprise-------------------------100.00%21.77%-100.00%-100.00%-100.00%-100.00%-100.00%--99.02%--99.16%--99.16%--99.15%--99.07%--99.06%--102.64%--99.10%--99.91%--101.66%--98.49%--98.70%--99.17%--100.00%--100.00%---22.08%-12.96%-
Timing---------------------------Pre-marketPre-marketPre-marketPre-market-Pre-market-Pre-marketAfter-hoursPre-market-Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours-After-hours-----

Key Statistics & Ratios

Market Cap31.22B
Enterprise Value41.02B
Trailing P/E11.09
Forward P/E14.14
PEG Ratio2.11
Price / Sales2.29
Price / Book5.60
EPS4.44
Book Value8.93
Revenue (TTM)13.64B
Gross Profit (TTM)8.12B
EBITDA3.59B
Profit Margin21.09%
Operating Margin18.19%
Return on Equity48.02%
Return on Assets7.88%
Shares Outstanding633.91M
Shares Float630.15M
Beta0.25
Dividend Yield4.39%
Dividend Rate2.16
Payout Ratio48.63%

Dividends

20263×
0.89Aug 6, 20261.28Apr 9, 20262.45Feb 2, 2026
20252×
0.88Aug 7, 20251.27Apr 10, 2025
20242×
0.84Aug 1, 20241.21Apr 11, 2024
20232×
0.80Aug 3, 20231.15Apr 6, 2023
20222×
0.76Aug 4, 20221.06Apr 28, 2022
20212×
0.76Aug 5, 20211.06May 6, 2021
20202×
0.76Aug 20, 20201.06Apr 16, 2020
20192×
0.76Aug 22, 20191.04Apr 18, 2019
20182×
0.73Aug 16, 20181.02Apr 12, 2018
20172×
0.69Aug 17, 20170.99Apr 13, 2017
20162×
0.61Aug 18, 20160.92Apr 14, 2016
20151×
0.52Aug 13, 2015

Stock Splits

  • Feb 2, 202624:25